Xiaotao Jiang

445 total citations
25 papers, 283 citations indexed

About

Xiaotao Jiang is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaotao Jiang has authored 25 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaotao Jiang's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (4 papers). Xiaotao Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (4 papers). Xiaotao Jiang collaborates with scholars based in China and Australia. Xiaotao Jiang's co-authors include Yi Wen, Fengbin Liu, Yanhua Yan, Kechao Nie, Zhihua Zheng, Peiwu Li, Fengbin Liu, Yi Wen, Yuancheng Huang and Peng Liu and has published in prestigious journals such as Medicine, BioMed Research International and Genomics.

In The Last Decade

Xiaotao Jiang

24 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaotao Jiang China 10 136 116 112 64 41 25 283
Youxiang Chen China 9 121 0.9× 93 0.8× 65 0.6× 90 1.4× 53 1.3× 59 297
Yuzhou Qin China 14 184 1.4× 149 1.3× 87 0.8× 62 1.0× 56 1.4× 25 321
Huanqiu Chen China 8 155 1.1× 110 0.9× 52 0.5× 45 0.7× 46 1.1× 18 236
Ziyi Wang China 10 145 1.1× 73 0.6× 197 1.8× 64 1.0× 52 1.3× 21 314
Yunhong Tian China 10 123 0.9× 77 0.7× 76 0.7× 77 1.2× 106 2.6× 29 307
Lihuan Zhu China 11 103 0.8× 56 0.5× 89 0.8× 65 1.0× 56 1.4× 29 278
Ileana Skalamera Italy 6 91 0.7× 54 0.5× 114 1.0× 86 1.3× 70 1.7× 11 250
Ashley Russo United States 9 86 0.6× 73 0.6× 161 1.4× 134 2.1× 63 1.5× 20 322
Kai Zheng China 8 183 1.3× 127 1.1× 45 0.4× 30 0.5× 39 1.0× 26 303

Countries citing papers authored by Xiaotao Jiang

Since Specialization
Citations

This map shows the geographic impact of Xiaotao Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaotao Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaotao Jiang more than expected).

Fields of papers citing papers by Xiaotao Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaotao Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaotao Jiang. The network helps show where Xiaotao Jiang may publish in the future.

Co-authorship network of co-authors of Xiaotao Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaotao Jiang. A scholar is included among the top collaborators of Xiaotao Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaotao Jiang. Xiaotao Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jiang, Xiaotao, et al.. (2025). Eleutheroside A inhibits PI3K/AKT1/mTOR-mediated glycolysis in MDSCs to alleviate their immunosuppressive function in gastric cancer. International Immunopharmacology. 159. 114907–114907. 2 indexed citations
3.
Chen, Chengcong, Yongjun Zhou, Libo Tang, et al.. (2024). Anti-HBc mirrors the activation of HBV-specific CD8+ T cell immune response and exhibits a direct effect on HBV control. Antiviral Research. 230. 105975–105975. 1 indexed citations
4.
Rosario, Vinicius do, Henry Brodaty, Kaarin J. Anstey, et al.. (2024). Assessing the effect of anthocyanins through diet and supplementation on cognitive function in older adults at risk for dementia: protocol for a randomised controlled trial. BMJ Open. 14(9). e086435–e086435. 3 indexed citations
6.
Huang, Yuancheng, Xiaotao Jiang, Yanhua Yan, et al.. (2022). Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis. Frontiers in Genetics. 13. 816173–816173. 16 indexed citations
7.
Jiang, Xiaotao, Yi Wen, Yanhua Yan, et al.. (2021). CXCR4 is a Novel Biomarker Correlated With Malignant Transformation and Immune Infiltrates in Gastric Precancerous Lesions. Frontiers in Molecular Biosciences. 8. 697993–697993. 1 indexed citations
8.
Jiang, Xiaotao, Fan Liu, Peng Liu, et al.. (2021). Ferroptosis Patterns Correlate with Immune Microenvironment Characterization in Gastric Cancer. International Journal of General Medicine. Volume 14. 6573–6586. 5 indexed citations
9.
Jiang, Xiaotao, Yi Wen, Kechao Nie, et al.. (2021). Current Evidence and Future Perspective of Accuracy of Artificial Intelligence Application for Early Gastric Cancer Diagnosis With Endoscopy: A Systematic and Meta-Analysis. Frontiers in Medicine. 8. 629080–629080. 30 indexed citations
10.
Huang, Yuancheng, Zehong Yang, Xiaotao Jiang, et al.. (2021). Identification of N6-Methylandenosine-Related lncRNAs for Subtype Identification and Risk Stratification in Gastric Adenocarcinoma. Frontiers in Oncology. 11. 725181–725181. 11 indexed citations
11.
Yan, Yanhua, Kechao Nie, Xiaotao Jiang, et al.. (2021). High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma. Cancer Management and Research. Volume 13. 5013–5026. 11 indexed citations
12.
Jiang, Xiaotao, et al.. (2021). Identification of Vital Hub Genes and Potential Molecular Pathways of Dermatomyositis by Bioinformatics Analysis. BioMed Research International. 2021(1). 9991726–9991726. 6 indexed citations
13.
Nie, Kechao, Zhitong Deng, Zhihua Zheng, et al.. (2020). Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer. DNA and Cell Biology. 39(9). 1532–1544. 22 indexed citations
14.
Nie, Kechao, Zhihua Zheng, Yi Wen, et al.. (2020). Construction and validation of a TP53-associated immune prognostic model for gastric cancer. Genomics. 112(6). 4788–4795. 29 indexed citations
15.
Nie, Kechao, Zhihua Zheng, Yi Wen, et al.. (2020). A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer. International Immunopharmacology. 87. 106845–106845. 19 indexed citations
16.
Zheng, Zhihua, Yi Wen, Kechao Nie, et al.. (2020). Construction of a 13‐microRNA‐based signature and prognostic nomogram for predicting overall survival in patients with hepatocellular carcinoma. Hepatology Research. 50(10). 1151–1163. 7 indexed citations
17.
Qiu, Guoyu, et al.. (2020). Therapeutic efficacy and immunoregulatory effect of Qiangji Jianli Capsule for patients with myasthenia gravis. Medicine. 99(51). e23679–e23679. 5 indexed citations
18.
Jiang, Xiaotao, et al.. (2018). Berberine Combined with Triple Therapy versus Triple Therapy for Helicobacter pylori Eradication: A Meta‐Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2018(1). 8716910–8716910. 7 indexed citations
19.
Jiang, Xiaotao, et al.. (2018). Modified Buzhong Yiqi decoction for myasthenia gravis. Medicine. 97(50). e13677–e13677. 12 indexed citations
20.
Yao, Zhihong, Xiaotao Jiang, Kai Yuan, et al.. (2018). Diagnostic and prognostic implications of serum miR-101 in osteosarcoma. Cancer Biomarkers. 22(1). 127–133. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026